Business, energy, technology, markets and global industry news from Business News Today

PTSD

PharmaDeviceNews PTSD
Representative image of EEG-guided brain stimulation as Wave Neuroscience’s MeRT FDA clearance puts biomarker-led PTSD treatment, neuromodulation, and precision psychiatry under sharper focus.
Medical Devices & Diagnostics

Wave Neuroscience FDA clearance puts EEG-guided PTSD treatment closer to clinical adoption

Find out how Wave Neuroscience’s MeRT FDA clearance could reshape biomarker-guided PTSD treatment and precision psychiatry.

Read More
Representative image: A clinical neuropsychiatry consultation setting reflects ReST Therapeutics’ move to advance RST-101 into human testing for early PTSD treatment.
Pharma & Biotech

ReST Therapeutics wins FDA IND acceptance for RST-101 as early PTSD treatment strategy enters human testing

ReST Therapeutics’ RST-101 enters human testing for early PTSD. Find out why this IND acceptance could reshape trauma care.

Read More
Pharma & Biotech

Is lysergide finally going mainstream? Definium Therapeutics bets on DT120 ODT clinical momentum

Can DT120 ODT transform mental health treatment? Explore Definium Therapeutics’ pivotal trials and what they mean for psychedelic psychiatry.

Read More
Pharma & Biotech

Can TN-001 avoid hallucinogenic pitfalls while delivering rapid antidepressant effects?

Transneural’s TN-001 shows rapid neuroplasticity without hallucinogenic effects. Find out what this could mean for MDD and PTSD treatment strategies.

Read More